Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial
Open accessPublished version of a preprint
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Background: Mesenchymal stem cell (MSC) infusion was reported to improve liver function in patients with decompensated liver cirrhosis (DLC); however, whether the medication can improve outcome of these patients is poorly understood. Methods: This prospective, open-labeled, randomized controlled study enrolled 219 patients with HBV-related DLC who were divided into control group ( n = 111) and umbilical cord-derived MSC (UC-MSC)-treated group ( n = 108), then all of them received a follow-up check from October 2010 to October 2017. The treated patients received three times of UC-MSC infusions at 4-week intervals plus conventional treatment that was only used for control group. The overall survival rate and HCC-free survival rate were calculated as primary endpoints and the liver function and adverse events associated with the medication were also evaluated. Results: During the follow-up check period from 13 to 75th months, there was a significantly higher overall survival rate in the treated group than the control group, while the difference of the hepatocellular carcinoma event-free survival rate between the treated and control groups was not observed during the 75-month follow-up. UC-MSC treatment markedly improved liver function, as indicated by the levels of serum albumin, prothrombin activity, cholinesterase, and total bilirubin during 48 weeks of follow-up. No significant side effects or treatment-related complications were observed in the UC-MSC group. Conclusions: Therapy of UC-MSC is not only well tolerated, but also significantly improves long-term survival rate, as well as the liver function in patients with HBV-related DLC. UC-MSC medication, therefore, might present a novel therapeutic approach for the disease. Graphic abstract:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common side effect observed was fever, which could be subsided by regular antipyretics [287, 292, 300].”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [287]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to the control group, the treated group had a significantly higher overall survival rate from 13 to 75 months and markedly improved liver functions, as evidenced by serum ALB, PTA, CHE, and TBIL levels during 48 weeks.”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [287]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60690-x · Cited by 2,695
Røsland, G. V., Svendsen, A., Torsvik, A., Sobala, E., McCormack, E., Immervoll, H., Mysliwietz, J., Tonn, J.-C., Goldbrunner, R., Lønning, P. E., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4630 · Cited by 644
Kharaziha, P., Hellström, P. M., Noorinayer, B., Farzaneh, F., Aghajani, K., Jafari, F., Telkabadi, M., Atashi, A., Honardoost, M., Zali, M. R., et al. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832a1f6c · Cited by 492 · cited 1×
“In the clinical setting, several studies have shown that infusions of autologous BM-MSC can significantly improve liver function in patients with liver cirrhosis [6, 7].”
BackgroundTerai, S., Ishikawa, T., Omori, K., Aoyama, K., Marumoto, Y., Urata, Y., Yokoyama, Y., Uchida, K., Yamasaki, T., Fujii, Y., et al. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0542 · Cited by 491
Ramasamy, R., Lam, E. W.-F., Soeiro, I., Tisato, V, Bonnet, D., & Dazzi, F. (2007) · Leukemia · doi:10.1038/sj.leu.2404489 · Cited by 404
Shi, M., Zhang, Z., Xu, R., Lin, H., Fu, J., Zou, Z., Zhang, A., Shi, J., Chen, L., Lv, S., et al. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0034 · Cited by 374
Self-citationZhang, Z., Lin, H., Shi, M., Xu, R., Fu, J., Lv, J., Chen, L., Lv, S., Li, Y., Yu, S., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07024.x · Cited by 372 · cited 2×
“Our previous studies showed that UC-MSC infusion significantly improved liver function in patients with decompensated liver cirrhosis [12] and primary biliary cirrhosis [13] and increased the survival rates of patients with acute-on-chronic liver failure (ACLF) [14].”
BackgroundSelf-citationPeng, L., Xie, D.-Y., Lin, B.-L., Liu, J., Zhu, H.-P., Xie, C., Zheng, Y.-B., & Gao, Z.-L. (2011) · Hepatology · doi:10.1002/hep.24434 · Cited by 365
Cited by
Items 101–152 of 152
Zhang, Z., Xu, A., Zhou, Q., Wen, F., Chen, F., Chen, H., Wang, H., Chen, L., Ju, Z., & Ge, Y. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae065 · Cited by 1
Human stem cells for decompensated cirrhosis in adults
Aung, H. H., Naing, C. M., Ni, H., Aye, S. N., Htet, N. H., Kew, S. T., & Pavlov, C. S. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015173.pub2 · Cited by 2
Mesenchymal stem cell therapy for endometrial injury: a meta-analysis of preclinical studies
Liu, Y., Koubanani, Z. G., Jia, D., & Ma, M. (2025) · BMC Women s Health · doi:10.1186/s12905-025-04211-2 · Cited by 2
Xie, W., Luo, T., Tang, G., Ma, Z., Gong, J., Yang, T., Zhou, J., & Song, Z. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149698 · Cited by 2
Baer, H. U., Sulaiman, A. S., Wahyuni, N. T., Sutedja, B., Limas, P. I., Marcelina, O., Lheman, J., Nuraeni, Drew, C., & Hendrawan, S. (2025) · Journal of Liver Transplantation · doi:10.1016/j.liver.2025.100314 · Cited by 1
Stem Cell Therapy for Inflammatory Diseases: Progress, Challenges, and Future Directions
Wu, C., Jin, Z., Weng, S., Zhu, J., & Dong, L. (2026) · MedComm · doi:10.1002/mco2.70616 · Cited by 2
Interleukin 13 (IL-13) Signalling as a Potential Target for Cell Therapies in Liver Fibrosis
Mazurski, A., Bednarz, A., & Czekaj, P. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062735 · Cited by 1
Jin, L., Cao, K., Chen, H., Hou, J., Li, T., Zhang, Y., Chen, C., Ma, H., Jin, J., Qian, J., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04512-0 · Cited by 1
Self-citationdos Santos, L. G., Viana, A. R., Bernasconi, N. J., Basso, P. C., & Krause, A. (2024) · Arquivo Brasileiro de Medicina Veterinária e Zootecnia · doi:10.1590/1678-4162-13115 · Cited by 1
Harnessing the ubiquitin proteasome system as a key player in stem cell biology
Atta, H., Kassem, D. H., Kamal, M. M., & Hamdy, N. Μ. (2025) · BioFactors · doi:10.1002/biof.2157 · Cited by 1
Wen, Y., Li, J., Mukama, O., Huang, R., Deng, S., & Li, Z. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.03.007 · Cited by 1
Self-citationHan, Y., He, X.-M., Lee, S.-J., Mao, Y., Liu, X.-C., Sun, H., Jin, M., & Kwon, T. (2022) · Aging · doi:10.18632/aging.204344
Therapies related to mesenchymal stem cells for cartilage, joint, and bone diseases
Zhang, Y., Xu, T., Liu, M., & Yin, Z. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91938-8.00002-0 · Cited by 1
Feng, T., Shang, J., Lai, C., Yao, Y., Zhong, D., Yang, Q., Wang, S., Shi, Y., & Huang, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2029902/v1
Lan, T., Li, S., Yu, H., Kostallari, E., & Gao, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305666 · Cited by 1
ИССЛЕДОВАНИЕ ВОЗМОЖНОСТИ ЛЕЧЕНИЯ ЦИРРОЗА ПЕЧЕНИ С ИСПОЛЬЗОВАНИЕМ МЕЗЕНХИМАЛЬНЫХ СТВОЛОВЫХ КЛЕТОК
Akhayeva, T., ЖУСУПОВА, Г. Д., ГУРЦКАЯ, Г. М., Sakuov, Z. N., Mussazhanova, Z., Aralbaeva, A. N., & СЕЙТАЛИЕВА, А. М. (2023) · Farmaciâ Kazahstana · doi:10.53511/pharmkaz.2023.11.69.008
Qin, X., Chen, J., Du, L., Ma, Y., Li, Y., Lu, Y., Wang, Y., Wu, L.-F., Yu, Z., Hu, M., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3736389/v1
Self-citationZhao, Y., Huang, Y., & Li, W. (2024) · World Journal of Stem Cells · doi:10.4252/wjsc.v16.i6.615
Assessment of Short-Term Effects of Cell Transplantation in Cirrhosis DUE to HCV
АСТРАХАНОВ, А. Р., Saparbayev, S. S., Amanzholkyzy, A., Искакова, А. Н., Нурланова, Г. Н., & Kurmangazin, M. (2024) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2024.25.6.2099
Advances on the role of stem cells in liver cancer
Wang, Y., & Wang, J.-P. (2024) · New cell · doi:10.61958/ncst5135
Bone marrow mesenchymal stem cell transplantation for treatment of liver cirrhosis: Recent advances
Ruan, M.-F., Yin, Y.-H., Shao, X., & Qi, X. (2025) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v33.i2.106
Cell Therapy for Liver Cirrhosis
Liêm, N. T., & Dao, L. T. M. (2025) · Springer eBooks · doi:10.1007/978-981-96-1261-1_13
Stem cells for therapy of neurodegeneration
Полтавцева, Р. А., Svirshchevskaya, E. V., Tchikov, V. M., Bobkova, N. V., & Sukhikh, G. T. (2025) · Регенерация органов и тканей. · doi:10.60043/2949-5938-2024-3-14-32
Liu, Y., Dong, Y., Wu, X., Xu, X., & Niu, J. (2022) · Figshare · doi:10.6084/m9.figshare.19776329
Wang, H., Yao, W., Wang, Y., Dong, H., Dong, T., Zhou, W., Cui, L., Zhao, L., Zhang, Y., Shi, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24187912
Xie, Y., Yao, J., Yan, M., Lin, Y., Wei, J., Wang, H., Mao, Y., Liu, P., & Li, X. (2023) · Figshare · doi:10.6084/m9.figshare.24587682
Tian, S., Guo, G., Zhou, X., Liu, Y., Jia, G., Zheng, L., Cui, L., Wang, K., Zhang, M., Sun, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26659441
Lu, W., Qu, J., Yan, L., Tang, X., Wang, X., Ye, A., Zou, Z., Li, L., Ye, J., & Zhou, L. (2023) · Figshare · doi:10.6084/m9.figshare.24416123
Lu, W., Qu, J., Yan, L., Tang, X., Wang, X., Ye, A., Zou, Z., Li, L., Ye, J., & Zhou, L. (2024) · Figshare · doi:10.6084/m9.figshare.24416217
Liu, Y., Dong, Y., Wu, X., Xu, X., & Niu, J. (2022) · Figshare · doi:10.6084/m9.figshare.19776326
Yao, Y., Zhang, L., Cheng, F., Jiang, Q., Ye, Y., Ren, Y., He, Y., Su, D., Cheng, L., Shi, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26607010
Zhang, Z., Shang, J., Yang, Q., Dai, Z., Liang, Y., Lai, C., Feng, T., Zhong, D., Zou, H., Sun, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601654
Yao, Y., Zhang, L., Cheng, F., Jiang, Q., Ye, Y., Ren, Y., He, Y., Su, D., Cheng, L., Shi, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26607013
Yao, Y., Zhang, L., Cheng, F., Jiang, Q., Ye, Y., Ren, Y., He, Y., Su, D., Cheng, L., Shi, G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26607016
From initiation to maturation: Mesenchymal stem cells as key facilitators in organoid development
Yi, S., Wen, J., Wang, T., Yu, W., Liao, Y., Liu, Z., & Wang, H. (2026) · Cells and Development · doi:10.1016/j.cdev.2026.204071
Future of Regenerative Hepatology
Martínez-García, J., Blanes-Rodríguez, Á., Barbancho, S. M., Viartola, M. S., & Baptista, P. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-10997-2_23
Feng, Y., Qiu, Y., Zhang, S., Dai, K., Wang, J., & Liu, C. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.02.034 · Cited by 2
Research Progress on the Recompensation of Liver Cirrhosis
高, 源. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1631071
Stem Cells for the Therapy of Neurodegeneration
Полтавцева, Р. А., Svirshchevskaya, E. V., Tchikov, V. M., Bobkova, N. V., & Sukhikh, G. T. (2026) · Cell and Tissue Biology · doi:10.1134/s1990519x2603003x
Meng, C., Liu, M., Qi, Q., Cao, L., Lei, Q., Liu, X., & Wang, M. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s601322
Nguyen, L. L., Nguyen, H.-P., Bui, H. T., Nguyen, Q. T., Nguyen, P. V., & Ha, H. T. T. (2026) · Cell Transplantation · doi:10.1177/09636897261449975
Zhang, R., Liu, J., Shan, W., Wang, H., Gao, L., Li, Y., Fan, L., Yang, C., Li, G., & Liu, J. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06266-2
Self-citationStem cell therapies for liver cirrhosis: a GRADE evaluation through a systematic review
Prasad, M., Shenoy, P., Prabhakar, T., Gupta, S., Gupta, S., Gautam, S., Ghai, V. K., Saraa Angel, L., Keerthi, K., Vats, S., et al. (2026) · Annals of Hepatology · doi:10.1016/j.aohep.2026.102241
Li, M.-J., Zhao, W. B., Li, C.-Y., Li, Y.-L., Ren, S.-H., Li, J., Qiu, L., Yang, C. C.-K., Fan, F., & Yao, H. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1862138
Self-citationMesenchymal stem cells and extracellular vesicles in liver regeneration
Karnawat, K., Puthiyattil, N., Parthasarathy, R., Sekar, J. A., Elangbam, P., Roy, N., Gupta, K., Balachander, G. M., & Pai, R. R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45056-3.00017-0
Li, X. D., Li, Z., Liao, Q., Huang, Y. N., Liao, S., & Li, L. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-05105-2
A patient-driven agenda for liver cirrhosis research
Tavabie, O. D., Crisp, H., Griffiths, C., Allen, R. M., Ashborn, A., Hebditch, V., & Mehta, G. (2026) · Gut · doi:10.1136/gutjnl-2026-339715
Wang, Z., Liang, H., Tan, Y., Zhu, Q., Chi, A., Wang, Y., & Shi, X. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124491
Xiong, W., 杨忠霞, Qian, Z., 彭雪彬, Ying, L., & Xiaorong, M. (2026) · Liver Research · doi:10.1016/j.livres.2026.08.003
Liu, W., Wang, Y., An, W., Wang, X., Han, B., Tao, H., 张永利, Gong, F., Wang, X., & Wang, J. (2026) · Cells · doi:10.3390/cells15201884
Hamada, T., Maruya, Y., Nagai, K., Yamahara, K., Miyamoto, D., Hara, T., Imamura, H., Matsushima, H., Adachi, T., Yamamoto, H., et al. (2026) · Regenerative Therapy · doi:10.1016/j.reth.2026.101186
Stem cells for hepatic regeneration: Evaluating mechanisms, sources, and clinical outcomes
Dastmalchi, N., Rahbarghazi, R., Barzegari, A., Safaralizadeh, R., Mansoori, B., Khojasteh, S. M. B., & Hajiasgharzadeh, K. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102858
Metadata
- Authors
- Shi, M., Li, Y.-Y., Xu, R.-N., Meng, F.-P., Yu, S.-J., Fu, J.-L., Hu, J.-H., Li, J.-X., Wang, L.-F., Jin, L., & Wang, F.-S.
- Affiliations
- Chinese PLA General Hospital (CN)
- Corresponding author
- Shi, Ming
- Wang, Fu-Sheng
- Venue
- Hepatology International
- Published
- 2021-11-29
- Volume
- 15
- Issue
- 6
- Pages
- 1431-1441
- ISSN
- 1936-0533 (ISSN-L)
- 1936-0541
- PMC
- PMC8651584
- OpenAlex
- W3166597897
- Cited by
- 151
- References
- 32
- Citations by year
- 2026: 25 · 2025: 39 · 2024: 35 · 2023: 35 · 2022: 17
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Hepatology International (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- the National Key R&D Program of China (2017YFA0105703)
- National Natural Science Foundation of China (82070617)
- Innovative Research Group Project of the National Natural Science Foundation of China (81721002)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- mesenchymal stem cells, umbilical cord-derived stem cells, decompensated cirrhosis, HBV-related liver cirrhosis, stem cell therapy, overall survival, liver function, long-term follow-up, treatment safety
- MeSH terms
- Follow-Up Studies, Humans, Liver Cirrhosis, Prospective Studies, Treatment Outcome, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.